Amneal Pharmaceuticals, Inc. AMRX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2009-11-18
Chart by TradingView
7/9
Piotroski F — financial health
2.06
Altman Z″ — distress risk · grey
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $3.0B | $2.8B | $2.4B | $2.2B | $2.1B |
| Gross profit | $1.1B | $1.0B | $820.6M | $784.7M | $769.0M |
| Operating income | $394.1M | $249.3M | $204.4M | -$94.9M | $152.7M |
| Net income | $72.1M | -$116.9M | -$84.0M | -$270.6M | $13.2M |
| Operating cash flow | $340.0M | $295.1M | $345.6M | $65.1M | $241.8M |
| Free cash flow | $269.9M | $243.2M | $302.4M | $18.7M | $194.1M |
| Total assets | $3.7B | $3.5B | $3.5B | $3.8B | $3.9B |
| Shareholders' equity | -$71.3M | -$109.5M | $20.0M | $184.0M | $360.3M |
| Ratios | |||||
| Gross margin | 36.9% | 36.5% | 34.3% | 35.5% | 36.7% |
| Operating margin | 13.1% | 8.9% | 8.5% | -4.3% | 7.3% |
| Net margin | 2.4% | -4.2% | -3.5% | -12.2% | 0.6% |
| FCF margin | 8.9% | 8.7% | 12.6% | 0.8% | 9.3% |
| Return on assets | 2.0% | -3.3% | -2.4% | -7.1% | 0.3% |
| Return on equity | -101.0% | 106.7% | -419.7% | -147.1% | 3.7% |
| Debt / equity | -36.06× | -19.74× | 120.94× | 14.09× | 7.44× |
| Current ratio | 2.17 | 1.41 | 1.63 | 1.88 | 2.24 |
| Revenue growth | 8.0% | 16.7% | 8.2% | 5.7% | 5.1% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 276,637 | $3.4M |
| Point72 Asset Management, L.P. | 78,105 | $970,845 |
Why these scores methodology →
Piotroski F-score: 7/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 2.06 (grey)
- Working capital / assets 0.28
- Retained earnings / assets -0.145
- EBIT / assets 0.107
- Equity / liabilities -0.019
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001723128 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.